Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.110
-0.140 (-11.20%)
At close: Dec 20, 2024, 4:00 PM
1.100
-0.010 (-0.90%)
After-hours: Dec 20, 2024, 6:49 PM EST
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $6.03 million as of December 20, 2024. Its market cap has decreased by -15.94% in one year.
Market Cap
6.03M
Enterprise Value
1.94M
1-Year Change
-15.94%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $6.03M, a decrease of -99.47%. That is a compound annual growth rate of -77.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 6.03M | -4.84% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutera | 7.07M |
| T2 Biosystems | 7.03M |
| Vincerx Pharma | 6.94M |
| GRI Bio | 6.88M |
| Kindly MD | 6.87M |
| Quantum BioPharma | 6.77M |
| Adial Pharmaceuticals | 6.73M |
| PAVmed | 6.65M |